Treatment News : Having HIV Means Heart Health Medications May Be Overlooked

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » August 2014

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

August 27, 2014

Having HIV Means Heart Health Medications May Be Overlooked

AIDS 2014People with HIV treated at a major university are less likely to receive medications to support heart health than those who do not have HIV, aidsmap reports. Researchers at Duke University conducted a retrospective study of 890 people with HIV matched by age, sex and ethnicity with 807 HIV-negative people who were all cared for at Duke between 1996 and 2010. The findings were presented at the 20th International AIDS Conference (AIDS 2014) in Melbourne, Australia.

The proportion of each group of people with uncontrolled hypertension was essentially the same, including 17.6 percent of those living with HIV and 19.1 percent of the HIV-negative group. Nevertheless, among those with hypertension (high blood pressure), just 57.75 percent of the HIV-positive people received antihypertensive drugs, compared with 75 percent of the HIV-negative people. Similarly, while the median Framingham 10-year risk score was 4 percent among both groups, between the respective HIV-positive and HIV-negative groups, the following proportions were receiving medications for heart health: 11.5 percent and 22.8 percent received aspirin, 15.1 percent and 23.6 percent received statins, and 35.6 percent and 52 percent received antihypertensives.

After adjusting for various factors, the researchers found that having HIV was associated with a 47 percent reduced likelihood of receiving aspirin, a 30 percent reduced likelihood of receiving statins and a 37 percent reduced likelihood of receiving antihypertensives.

To read the MedPage Today story, click here.

To read the conference abstract, click here.

Search: HIV, heart health, aspirin, antihypertensives, statins, aidsmap, Duke University, 20th International AIDS Conference, AIDS 2014.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    andais
    Red House
    West Virginia


    InDefaultOf
    Seattle
    Washington


    Sexynyrican
    Brooklyn
    New York


    HOTROD2010
    houston
    Texas
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.